A detailed history of Voya Investment Management LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 70,440 shares of KYMR stock, worth $2.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,440
Previous 72,974 3.47%
Holding current value
$2.1 Million
Previous $1.86 Million 52.45%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$22.9 - $43.57 $58,028 - $110,406
-2,534 Reduced 3.47%
70,440 $2.83 Million
Q4 2023

Feb 14, 2024

SELL
$10.97 - $26.84 $230 - $563
-21 Reduced 0.03%
72,974 $1.86 Million
Q3 2023

Nov 14, 2023

BUY
$13.9 - $23.88 $4,392 - $7,546
316 Added 0.43%
72,995 $1.01 Million
Q2 2023

Aug 14, 2023

BUY
$22.4 - $34.92 $13,059 - $20,358
583 Added 0.81%
72,679 $1.67 Million
Q1 2023

May 15, 2023

SELL
$24.84 - $38.75 $4,545 - $7,091
-183 Reduced 0.25%
72,096 $2.14 Million
Q4 2022

Feb 14, 2023

BUY
$19.57 - $30.92 $399,912 - $631,850
20,435 Added 39.42%
72,279 $1.8 Million
Q3 2022

Mar 03, 2023

SELL
$20.91 - $34.27 $427,295 - $700,307
-20,435 Reduced 28.27%
51,844 $1.13 Million
Q3 2022

Nov 14, 2022

BUY
$20.91 - $34.27 $786,404 - $1.29 Million
37,609 Added 264.2%
51,844 $1.13 Million
Q2 2022

Aug 15, 2022

BUY
$14.13 - $42.55 $3,490 - $10,509
247 Added 1.77%
14,235 $280,000
Q1 2022

May 16, 2022

BUY
$35.3 - $64.68 $14,614 - $26,777
414 Added 3.05%
13,988 $592,000
Q4 2021

Feb 14, 2022

BUY
$49.91 - $65.56 $13,625 - $17,897
273 Added 2.05%
13,574 $861,000
Q3 2021

Nov 15, 2021

BUY
$47.8 - $66.66 $91,106 - $127,053
1,906 Added 16.73%
13,301 $781,000
Q2 2021

Aug 16, 2021

BUY
$31.08 - $51.95 $354,156 - $591,970
11,395 New
11,395 $553,000
Q1 2021

May 17, 2021

SELL
$35.64 - $85.46 $138,318 - $331,670
-3,881 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$28.07 - $87.83 $108,939 - $340,868
3,881 New
3,881 $241,000

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $1.63B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.